comparemela.com

Latest Breaking News On - Rapport therapeutics - Page 1 : comparemela.com

Rapport's Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test

Rapport's Stock Market Debut Reaps $154M as Novel Epilepsy Med Heads for Mid-Stage Test
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Goldman-sachs
Nasdaq
Johnson
Rapport-therapeutics
Third-rock-ventures
Johnson-innovation
Venture-partners
Sofinnova-ventures

Rapport Therapeutics, Inc. Plans $136 Million IPO for June 7th (RAPP)

Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an initial public offering (IPO) on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for […]

California
United-states
San-francisco
Delaware
Boston
Massachusetts
David-bredt
Eli-lilly
News-ratings-for-rapport-therapeutics-inc
University-of-california
Goldman-sachs
Rapport-therapeutics-inc

Rapport Therapeutics, Inc. (RAPP) Announces June 7th IPO

Rapport Therapeutics, Inc. (RAPP) expects to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company will be issuing 8,000,000 shares at a price of $16.00-$18.00 per share. Rapport Therapeutics, Inc. has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […]

San-francisco
California
United-states
Delaware
Boston
Massachusetts
David-bredt
Eli-lilly
Goldman-sachs
News-ratings-for-rapport-therapeutics-inc
Rapport-therapeutics-inc
University-of-california

Rapport Therapeutics, Inc. (RAPP) to Raise $136 Million in IPO

Rapport Therapeutics, Inc. (RAPP) is planning to raise $136 million in an IPO on Friday, June 7th, IPO Scoop reports. The company plans to issue 8,000,000 shares at a price of $16.00-$18.00 per share. The company has a market-cap of $601.4 million. Goldman Sachs, Jefferies, TD Cowen and Stifel served as the underwriters for the […]

California
United-states
San-francisco
Delaware
Boston
Massachusetts
David-bredt
Eli-lilly
Goldman-sachs
University-of-california
News-ratings-for-rapport-therapeutics-inc
Rapport-therapeutics-inc

Hedge Funds Hope to Cash in on Biopharma IPO

Hedge Funds Hope to Cash in on Biopharma IPO
institutionalinvestor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from institutionalinvestor.com Daily Mail and Mail on Sunday newspapers.

Raymond-kelleher
Cormorant-private-healthcare-fund
Cormorant-global-healthcare-master-fund
Rapport-therapeutics
Cormorant-asset
Global-healthcare-master-fund
Perceptive-advisors
Surveyor-capital
Third-rock-ventures
Johnson-innovation

vimarsana © 2020. All Rights Reserved.